Extension of composite tissue allograft survival across major histocompatibility barrier under short course of anti-lymphocyte serum and cyclosporine A therapy

Journal of Reconstructive Microsurgery

Volumn 19, Issue 4, 2003, Pages 249-255

  Ozer, Kagan ^a   Gurunluoglu, Raffi ^a   Zielinski, Maciej ^a   Izycki, Dariusz ^a   Unsal, Murat ^a   Siemionow, Maria ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Anti lymphocyte serum; Composite tissue allograft; Cyclosporine; Hindlimb; Rat

Indexed keywords

CYCLOSPORIN A; LYMPHOCYTE ANTIBODY;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCULATION; CHIMERA; COMPOSITE GRAFT; CONTROLLED STUDY; DONOR; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; ISOGRAFT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NONHUMAN; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RAT; RAT STRAIN; SURVIVAL TIME;

ANIMALS; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HINDLIMB; IMMUNOSUPPRESSIVE AGENTS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; RATS; RATS, INBRED LEW; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 0037981565     PISSN: 0743684X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40581     Document Type: Article

References (39)

1. Jones JW, Gruber SA, Barker JH, Breidenbach WC. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. N Engl J Med. 2000 Aug 17;343:468-473
2. Jones TR, Humphrey PA, Brennan DC. Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in a renal transplant patient. Transplant Proc 1998;30:2746-2753
3. Lorenz RR, Fritz MA, Strome M. Special feature: current state of laryngeal transplantation. Curr Opin Otolaryn Head Neck Surg 2001;9:381-386
4. Foster RP, Fan L, Niepp M, et al. Donor specific tolerance induction in composite tissue allografts. Am J Surg 1998;176:418-421
5. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by nonlethal preparative regimen. J Exp Med 1989;169:493-502
6. Qin S, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989;169:779-794
7. Colson YL, Wren SM, Schuchert MJ, et al. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J Immunol 1995;155:4179-4188
8. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995;59:256-262
9. th Annual Meeting, Plastic Surgery Research Council, Milwaukee, WI, June, 2001
10. White DJG, Plumb AM, Pawelec G, et al. Cyclosporine A: an immunosuppressive agent preferentially active against proliferating T cells. Transplantation 1979;27:55-58
11. Brent L. Immunoregulation: the search for the holy grail. In: Brent L, ed. History of Transplantation Immunology. San Diego: Academic Press, 1997:230-304
12. Press BHJ, Sibley RK, Shons AR. Limb allotransplantation in the rat: extended survival and return of nerve function with continuous cyclosporin/prednisone immunosuppression. Ann Plast Surg 1986;16:313-321
13. Hewitt CW, Black KS, Fraser LA, et al. Composite tissue (limb) allografts in rats. I: Dose-dependent increase in survival with cyclosporine. Transplantation 1985;39:360-364
14. Black KS, Hewitt CW, Fraser LA, et al. Composite tissue (limb) allografts in rats. II: Indefinite survival using low-dose cyclosporine. Transplantation 1985;39:365-368
15. Press BHJ, Sibley RK, Shons AR. Limb allotransplantation in the rat: extended survival and return of nerve function with continuous cyclosporin/prednisone immunosuppression. Ann Plast Surg 1986;16:313-321
16. Black KS, Hewitt CW, Hwang JS, et al. Dose response of cyclosporine-treated composite tissue allografts in a strong histoincompatible rat model. Transplant Proc 1988;20:266-268
17. Hotokebuchi T, Arai K, Takagishi K, et al. Limb allografts in rats immunosuppressed with cyclosporine: as a whole joint allograft. Plast Reconstr Surg 1989;83:1027-1036
18. Doi K, DeSantis G, Singer DI, et al. The effect of immunosuppression on vascularized allografts. J Bone Joint Surg 1989;71B:576-582
19. Arai K, Hotokebuchi T, Miyahara H, et al. Prolonged limb allograft survival with short-term treatment with FK-506 in rats. Transplant Proc 1989;21:3191-3193
20. Fealy MJ, Umansky WS, Bickel KD, et al. Efficacy of rapamycin and FK506 in prolonging rat hind limb allograft survival. Ann Surg 1994;219:88-93
21. Muramatsu K, Doi K, Shigetomi M, et al. A new immunosuppressant, FTY 720, prolongs limb allograft survival in rats. Ann Plast Surg 1998;40:160
22. Inceoglu S, Siemionow M, Chick L, et al. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind limb allografts. Ann Plast Surg 1994;33:57-65
23. Buttemeyer F, Jones NF, Min Z, Rao U. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plast Reconstr Surg 1996;97:139-148
24. Hewitt CW, Black KS, Fraser LA, et al. Cyclosporine A is superior to prior donor-specific blood transfusion for the extensive prolongation of rat limb allograft survival. Transplant Proc 1983;15:514-517
25. Salvatierra O, Vincenti F, Amend W, et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980;192:543-552
26. Barber WH, Mankin JA, Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation. 1991;51:70-75
27. Wolden SL, Tate DJ, Hunt SA, et al. Long-term results of total lymphoid irradiation in the treatment of cardiac allograft rejection. Int J Radiat Oncol Biol Phys. 1997;39:953-960
28. Zwan AV, Besseling AC, Waal LP, Boog CJP. Specific tolerance induction and transplantation: a single-day protocol. Blood 1997;89:2596-2601
29. El Badri NS, Good RA. Induction of immunological tolerance in full major and multiminor histocompatibility-disparate mice using a mixed bone marrow transplantation. Proc Soc Exp Med 1994;205:67-74
30. Fontes P, Rao AS, Demetris AJ, et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994;344:151-155
31. Rao AS, Fontes P, Zeevi A, et al. Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc 1995;27:210-212
32. Murase N, Demetris AJ, Fujisaki S, et al. Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. Transplant Proc 1995;27:174-175
33. Hanaway MJ, Geissler EK, Wang J, et al. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model. Transplantation 1996;61:1222-1228
34. Ishikura H, Natori T, Aizawa M. Host-origin dendritic cells in acutely rejected rat renal allografts. Transplant Proc 1985;17:875-879
35. Katz SM, Carmer DV, Kunz HW, et al. Effect of major histocompatibility complex genetic disparities on cardiac and skin graft rejection in the rat. Transplantation 1983;36:463-464
36. Terasaki PI, Cho Y, Takemoto S, et al. Twenty year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival. Transplant Proc 1996;28:1144-1145
37. Tsuchimoto S, Mizuno K, Matsuno Y, et al. The effect of RT1 subregion differences on liver allograft survival in the rat. Transplantation 1985;40:218-220
38. Iwasaki N, Gohda T, Itoga H, et al. Effects of major histocompatibility complex matching in graft survival in allogeneic rat hind limb transplantation. J Hand Surg 2001;26A:540-545
39. Gill TJ III, Kunz HW, Misra DN, et al. The major histocompatibility complex of the rat. Transplantation 1987;43:773-785